(July 25, 2023, 1:54 PM EDT) -- PHILADELPHIA — The Third Circuit U.S. Court of Appeals on July 24 sidestepped a question about whether a generic drugmaker adequately warned about the risks of the heart drug amiodarone under New Jersey’s product liability law because it found that the claims are preempted by federal law....